Literature DB >> 11481215

Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors.

A Slominski1, J Wortsman, A Pisarchik, B Zbytek, E A Linton, J E Mazurkiewicz, E T Wei.   

Abstract

Studies in mammalian skin have shown expression of the genes for corticotropin-releasing hormone (CRH) and the related urocortin peptide, with subsequent production of the respective peptides. Recent molecular and biochemical analyses have further revealed the presence of CRH receptors (CRH-Rs). These CRH-Rs are functional, responding to CRH and urocortin peptides (exogenous or produced locally) through activation of receptor(s)-mediated pathways to modify skin cell phenotype. Thus, when taken together with the previous findings of cutaneous expression of POMC and its receptors, these observations extend the range of regulatory elements of the hypothalamic-pituitary-adrenal axis expressed in mammalian skin. Overall, the cutaneous CRH/POMC expression is highly reactive to common stressors such as immune cytokines, ultraviolet radiation, cutaneous pathology, or even the physiological changes associated with the hair cycle phase. Therefore, similar to its central analog, the local expression and action of CRH/POMC elements appear to be highly organized and entrained, representing general mechanism of cutaneous response to stressful stimuli. In such a CRH/POMC system, the CRH-Rs may be a central element.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481215     DOI: 10.1096/fj.00-0850rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  97 in total

Review 1.  Stress and the hair follicle: exploring the connections.

Authors:  Vladimir A Botchkarev
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

3.  Lipopolysaccharide upregulates the expression of corticotropin-releasing hormone via MAP kinase pathway in rat peritoneal macrophages.

Authors:  Wuchao Wang; Xiuzhu Zhang; Lie Yang; Dawei Liu; Guodong Liu; Jihong Zhou
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

4.  CRH functions as a growth factor/cytokine in the skin.

Authors:  A Slominski; B Zbytek; A Pisarchik; R M Slominski; M A Zmijewski; J Wortsman
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

Review 5.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 6.  Neuroendocrine system of the skin.

Authors:  Andrzej Slominski
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

7.  The stressed gut: contributions of intestinal stress peptides to inflammation and motility.

Authors:  Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-17       Impact factor: 11.205

8.  Bioactive forms of vitamin D selectively stimulate the skin analog of the hypothalamus-pituitary-adrenal axis in human epidermal keratinocytes.

Authors:  Justyna M Wierzbicka; Michał A Żmijewski; Anna Piotrowska; Boguslaw Nedoszytko; Magdalena Lange; Robert C Tuckey; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2016-08-12       Impact factor: 4.102

9.  Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20--emerging role of soluble isoforms.

Authors:  M A Zmijewski; A T Slominski
Journal:  J Physiol Pharmacol       Date:  2009-10       Impact factor: 3.011

Review 10.  The emerging role of peripheral corticotropin-releasing hormone (CRH).

Authors:  I Ilias; G Mastorakos
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.